First Glucocorticoid RA Approved for Ovarian Cancer

Relacorilant enhances chemotherapy sensitivity in platinum-resistant disease.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/first-glucocorticoid-receptor-antagonist-approved-ovarian-2026a100096f?src=rss

Author :

Publish date : 2026-03-25 20:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

First Glucocorticoid RA Approved for Ovarian Cancer

FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer

Meta and YouTube fined $3 million for harming mental health

Related Posts

Ultrasound delays putting pregnant women and cancer patients at risk, sonographers say

Are UK students at risk of more deadly meningitis outbreaks?

Supplement Makers Push FDA to Allow Peptides and Other New Ingredients

Senate Democrats Blast Latest Affordable Care Act Proposal From CMS

Mammography Use Declined Among Younger Women in Recent Years

CDC Report Spots Decreasing Coverage of 5 Vaccines

Ultrasound delays putting pregnant women and cancer patients at risk, sonographers say

Are UK students at risk of more deadly meningitis outbreaks?

Supplement Makers Push FDA to Allow Peptides and Other New Ingredients

Senate Democrats Blast Latest Affordable Care Act Proposal From CMS

Mammography Use Declined Among Younger Women in Recent Years

CDC Report Spots Decreasing Coverage of 5 Vaccines

First Once-Weekly Basal Insulin Approved for Type 2 Diabetes

Brain Disease Decades Later? Study Links Childhood Surgery to Amyloid Build-Up

Categories

Archives